Wikidata

(Q64172408)

English

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

clinical trial

In more languages

Statements

short name
CheckMate743 (English)
0 references
title
A Phase III, Randomized, Open Label Trial of Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma (English)
0 references
country
Australia
0 references
Belgium
0 references
Brazil
0 references
Chile
0 references
Colombia
0 references
France
0 references
Germany
0 references
Greece
0 references
Italy
0 references
Japan
0 references
Mexico
0 references
Netherlands
0 references
Poland
0 references
Romania
0 references
South Africa
0 references
Switzerland
0 references
Turkey
0 references
United Kingdom
0 references
start time
25 October 2016
0 references
end time
4 October 2020
0 references
number of participants
600
0 references
research intervention
carboplatin
0 references
pemetrexed
0 references
cisplatin
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64172408&oldid=1857589264"